Ra Pharmaceuticals Stock Price - RARX

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 46.10 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Ra Pharmaceuticals Inc RARX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.10 -0.22% 46.10 46.21 46.09 46.20 46.20 17:59:46
Bid Price Ask Price Spread Spread % News
45.75 46.67 0.92 1.97% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,121 821,673 $ 46.16 $ 37,932,050 1,620,884 11.2713 - 47.40
Last Trade Time Type Quantity Stock Price Currency
17:39:24 formt 8,944 $ 46.10 USD

Ra Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.17B 47.01M $ -64.94M -2.07 - 46.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 15.00 0.60%

more financials information »

Ra Pharmaceuticals News

Date Time Source News Article
10/17/201919:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/17/201919:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/17/201914:12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
10/11/201916:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
10/10/201914:21PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra..
10/10/201909:05Edgar (US Regulatory)Current Report Filing (8-k)
10/10/201909:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)

Latest RARX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RARX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week46.9047.0146.043946.431,327,318-0.80-1.71%
1 Month24.4647.4022.2543.732,480,53721.6488.47%
3 Months33.8947.4022.2540.351,146,42812.2136.03%
6 Months21.2747.4019.6436.63763,01824.83116.74%
1 Year16.4747.4011.271330.46620,85229.63179.9%
3 Years14.1647.404.7823.72327,83031.94225.56%
5 Years14.1647.404.7823.72327,83031.94225.56%

Ra Pharmaceuticals Description

Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its lead product candidate is RA101495, an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), as well as for the treatment of other debilitating complement-mediated diseases, including refractory generalized myasthenia gravis and lupus nephritis. Geographically business of the firm can be seen amplifying in the United States, Europe and even at international level.
Your Recent History
NASDAQ
RARX
Ra Pharmac..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191024 04:09:28